Results 171 to 180 of about 472,200 (335)

Sustainable Walnut Shell‐Filled Polylactic Acid–Hydroxyapatite Hybrid Coatings for Enhanced Corrosion Resistance and Bioactivity of Magnesium Biomaterials

Journal of Applied Polymer Science, EarlyView.
ABSTRACT Due to the high corrosion rate and limited biocompatibility of commonly used magnesium (Mg) and its alloys, current studies have focused on surface modification techniques. In this study, which is aimed at overcoming these obstacles in biomedical applications, hybrid coatings of PLA‐HA‐Walnut shell (Wshell) were successfully applied to Mg ...
Mehmet Topuz, Fatma Coskun Topuz, Burak Dikici, Davod Seifzadeh   +3 more
wiley   +1 more source

Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025

Journal of Bone and Mineral Research, 2007
R. Burge, B. Dawson-Hughes, D. Solomon, J. Wong, Alison B King, A. Tosteson   +5 more
semanticscholar   +1 more source

Metabolomic analysis reveals the molecular mechanism related to leg abnormality in broilers

Animal Research and One Health, EarlyView.
The graphical abstract shows the principal results of this study. Compared to the leg normal broilers, the serum calcium to phosphorus ratio was extremely decreased in the group with deformed leg bones. Additionally, a total of nine differential metabolites significantly associated with leg abnormalities and serum calcium and phosphorus levels were ...
Jumei Zheng, Qi Zhang, Xinxin Tang, Fan Ying, Dawei Liu, Sen Li, Ranran Liu, Jie Wen, QingHe Li, Guiping Zhao   +9 more
wiley   +1 more source

Steroid Osteoporosis [Abridged] [PDF]

, 1960
P. Hume Kendall
openalex   +1 more source

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis &Rheumatology, EarlyView.
Objective An unmet need exists for glucocorticoid‐sparing treatments for patients with polymyalgia rheumatica (PMR). The antibody‐drug conjugate ABBV‐154 comprises adalimumab conjugated to a glucocorticoid receptor modulator. We evaluated ABBV‐154 versus placebo in patients with glucocorticoid‐dependent PMR.
Robert F. Spiera, Valerie Devauchelle‐Pensec, Claire E. Owen, Federico Díaz‐González, Tsutomu Takeuchi, Edit Drescher, Jaclyn Anderson, Dilek Arikan, Ronilda D'Cunha, Julie Parmentier, Denise T. Kruzikas, Weihan Zhao, Yang Yang, Karen Stellpflug, Frank Buttgereit   +14 more
wiley   +1 more source

OSTEOPOROSIS OF THE HUMERUS FOLLOWING FRACTURE

, 1929
Nicholas S. Ransohoff
openalex   +2 more sources

Effect of sex hormones on bone in primary osteoporosis [PDF]

, 1969
B. Lawrence Riggs, Jenifer Jowsey, Patrick J. Kelly, James D. Jones, Frank T. Maher   +4 more
openalex   +1 more source

Treated Osteoporosis Is Still Osteoporosis [PDF]

Journal of Bone and Mineral Research, 2019
Neil Binkley, E. Michael Lewiecki, John P. Bilezikian   +2 more
openaire   +3 more sources

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

Arthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

Impact of patient education by nurse case managers on decision making for out-of-pocket anti-osteoporotic pharmaceutical therapy: a single-center retrospective study

BMC Nursing
Background Osteoporosis is a common condition that increases the risk of fracture and mortality. In Taiwan, clinical guidelines recommend pharmaceutical therapy for patients with a T-score of ≤ − 2.5; however, Taiwan’s National Health Insurance (NHI ...
Ya-Lian Deng, Hsu-Tung Lee, Shih-Yi Lin, Tan-Hsiu Liao, Chia-Tien Hsu   +4 more
doaj   +1 more source